Pneumocystis Jirovecii Pneumonia Complicating Treatment With Infliximab (original) (raw)
Pneumocystis carinii Pneumonia During Maintenance Anti???Tumor Necrosis Factor?? Therapy with Infliximab for Crohn???s Disease
William Sandborn
Inflammatory bowel diseases, 2004
View PDFchevron_right
Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: A retrospective review and case-control study of 21 patients
Yoshiya Tanaka
Arthritis & Rheumatism, 2009
View PDFchevron_right
Pneumocystis jirovecii colonization in patients treated with infliximab
Francisco Medrano
European Journal of Clinical Investigation, 2011
View PDFchevron_right
Pneumocystis jirovecii pneumonia in a patient with melanoma treated with infliximab and corticosteroids for ipilimumab-associated colitis
Maria Marples
Global Dermatology
View PDFchevron_right
Severe Legionella pneumophila pneumonia following infliximab therapy in a patient with Crohnʼs disease
Matthias Jürgens
Inflammatory Bowel Diseases, 2009
View PDFchevron_right
Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case–control study of 17 patients
Fumikazu Sakai
Modern Rheumatology, 2013
View PDFchevron_right
Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib
Juan Gea-Banacloche
Blood, 2016
View PDFchevron_right
Pneumocystis jirovecii following rituximab
Philip Courtney
Rheumatology, 2021
View PDFchevron_right
Pneumocystis pneumonia complicating immunosuppressive therapy in Crohns disease: A preventable problem?
Omer Mahmoud Abdallah Omer
Frontline Gastroenterology, 2014
View PDFchevron_right
Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab
Bunyamin Kisacik
Scandinavian Journal of Infectious Diseases, 2007
View PDFchevron_right
Pneumocystis Jiroveci Mimicking COVID-19 Pneumonia in a Patient who is Receiving Ipilimumab and Nivolumab Combination Therapy: A Case Report
hilmi kodaz
View PDFchevron_right
Pneumocystis jirovecii Pneumonia in a Patient with Rheumatoid Arthritis Treated with Abatacept
FABIO LEON RODRIGUEZ OSPINA
Case Reports in Rheumatology, 2014
View PDFchevron_right
Methotrexate-Induced Pneumocystis Jirovecii Pneumonia in a Patient with Rheumatoid Arthritis: A Case Report
João Rua
2020
View PDFchevron_right
Pneumocystosis in a patient with Crohn's disease treated with combination therapy with adalimumab
ANA ISIS DESALES
Journal of Crohns & Colitis
View PDFchevron_right
Pneumocystis jirovecii pneumonia in two patients with systemic lupus erythematosus after rituximab therapy
Carlos Cañas
Clinical Rheumatology, 2014
View PDFchevron_right
Severe adenovirus pneumonia (AVP) following infliximab infusion for the treatment of Crohn's disease
nasir ahmad
Journal of Infection, 2007
View PDFchevron_right
Pneumocystis jiroveci Pneumonia in an Atypical Host
Rachel Layman
Clinical Breast Cancer, 2012
View PDFchevron_right
Successful resolution of pneumonia developed in a patient affected by Crohn’s disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor α inhibitors and conventional immunosuppressive drugs
Piero Vernia
Rheumatology International, 2010
View PDFchevron_right
Severe pneumocystis jiroveci pneumonia in a patient on temozolomide therapy: A case report and review of literature
Sania Khan
Respiratory Medicine Case Reports, 2017
View PDFchevron_right
Legionella pneumonia after infliximab in a patient with Rheumatoid Arthritis
Giovana Ribeiro, Sonia Fialho
Revista Brasileira de Reumatologia (English Edition), 2014
View PDFchevron_right
Pneumocystis Infection in Two Patients Treated with Both Immune Checkpoint Inhibitor and Corticoids
Angela Loizidou
Journal of Immunotherapy and Precision Oncology, 2020
View PDFchevron_right
Review of pulmonary adverse effects of infliximab therapy in Crohn's disease
Lokesh Guglani
View PDFchevron_right
Pneumocystis pneumonia induced by treatment with low-dose tacrolimus and methylprednisolone in a patient with rheumatoid arthritis: a case report
Isao Kobayashi
BMC Research Notes, 2013
View PDFchevron_right
Epidemiological and clinical characteristics of immunocompromised patients infected with Pneumocystis jirovecii in a twelve-year retrospective study from Norway
Raisa Hannula
BMC Infectious Diseases, 2021
View PDFchevron_right
Severe gram positive bacterial infection in an ulcerative colitis patient treated with Infliximab
jose brito
Journal of Crohn's and Colitis, 2010
View PDFchevron_right
Clinical Picture of Pneumocystis jiroveci Pneumonia in Cancer Patients
Guillaume Thiéry
Chest, 2007
View PDFchevron_right
Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: An Australian and New Zealand experience
Richard Gearry
Journal of Gastroenterology and Hepatology, 2010
View PDFchevron_right
Infliximab for pediatric patients with Crohn’s disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan
Satoshi Motoya
PLOS ONE, 2018
View PDFchevron_right
Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients
Marianne Lebbad
Annals of Hematology, 2010
View PDFchevron_right
Cough and fever in a female with Crohn's disease receiving infliximab
I. Kalomenidis
European Respiratory Journal, 2005
View PDFchevron_right
Severe Acute Respiratory Distress Syndrome during Infliximab Therapy in a Patient with Crohn Disease
Onnen Moerer
Case Reports in Gastroenterology, 2016
View PDFchevron_right
Acute Dermato-Lymphangio-Adenitis Following Administration of Infliximab for Crohn's Disease
Isurujith Liyanage
ACG Case Reports Journal, 2019
View PDFchevron_right
The safety profile of infliximab in patients with Crohn’s disease: The Mayo Clinic experience in 500 patients
Jean-frédéric Colombel
Gastroenterology, 2004
View PDFchevron_right